Spark Therapeutics buy melinda
Start price
09.08.18
/
50%
€51.46
Target price
08.11.18
€69.91
Performance (%)
-21.82%
End price
08.11.18
€40.23
Summary
This prediction ended on 08.11.18 with a price of €40.23. The prediction for Spark Therapeutics disappointed with a performance of -21.82%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - |
| iShares Core DAX® | 1.662% | 4.835% | 17.361% | 19.329% |
| iShares Nasdaq 100 | 0.667% | 0.000% | 38.234% | 55.157% |
| iShares Nikkei 225® | -2.139% | -4.786% | 13.099% | 7.393% |
| iShares S&P 500 | 0.564% | 0.775% | 29.181% | 46.527% |
Comments by melinda for this prediction
In the thread Spark Therapeutics diskutieren
SecteurRecherche biotechnologique et médicale Agenda 07/11 Publication de résultats
Develops therapy products for debilitating diseases
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies.
Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases.
The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies.
Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases.
The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.
(Vom Mitglied beendet)
Stopped prediction by melinda for Spark Therapeutics
Spark Therapeutics
Start price
Target price
Perf. (%)
€58.85
08.03.18
08.03.18
€67.65
19.03.18
19.03.18
3.46%
19.03.18
19.03.18
Spark Therapeutics
Start price
Target price
Perf. (%)
€80.30
06.10.17
06.10.17
€81.18
11.12.17
11.12.17
-48.25%
11.12.17
11.12.17
Spark Therapeutics
Start price
Target price
Perf. (%)
€54.77
18.07.17
18.07.17
€58.18
20.07.17
20.07.17
7.00%
20.07.17
20.07.17
Spark Therapeutics
Start price
Target price
Perf. (%)
€60.72
18.07.17
18.07.17
€64.50
20.07.17
20.07.17
7.00%
20.07.17
20.07.17
Spark Therapeutics
Start price
Target price
Perf. (%)
€49.78
10.03.17
10.03.17
€58.63
20.03.17
20.03.17
4.96%
20.03.17
20.03.17